Results 41 to 50 of about 8,269 (177)
Abstract Craniopharyngiomas are histologically and cytologically benign epithelial tumors of the central nervous system that may be locally aggressive and tend to recur after excision. Malignant change in craniopharyngiomas is extremely rare; we found only 4 such reports in the literature.
T, Kristopaitis +3 more
openaire +2 more sources
Understanding the Symptom Burden of Complex Skull Base Tumors From the Patient's Perspective
ABSTRACT Background Symptom burden of skull base tumor (SBT) patients, especially those undergoing multimodality treatment, is poorly understood. We aim to understand symptom burden in this patient group using the core module the MD Anderson Symptom Inventory (MDASI).
Shirley Y. Su +8 more
wiley +1 more source
Craniopharyngioma (CP) is a rare intracranial tumor arising from the epithelial remnants of Rathke's pouch, most frequently originating in the sellar/parasellar region.
Maryam Nashi Alboqami +9 more
doaj +1 more source
Abstract Background Diagnosing malnutrition in patients with pediatric cancer is challenging because tumor masses can interfere with anthropometric measurements. STRONGkids considers cancer a general risk factor, whereas Screening Tool for Childhood Cancer (SCAN) classifies patients as at risk or not, potentially missing those who need nutrition ...
Cristiane Ferreira Marçon +2 more
wiley +1 more source
Craniopharyngioma in Adults [PDF]
Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary type.
Zoicas, Flavius, Schöfl, Christof
openaire +3 more sources
Voluminous craniopharyngioma evolving since childhood revealed by a torticollis
In case of a torticollis or a stature-weight growth delay in a child, it is always necessary to eliminate a cerebral tumor in the first place, especially a craniopharyngioma.
Ikram Damoune +2 more
doaj +1 more source
Malignant craniopharyngiomas: Institutional experience and literature review
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen +10 more
wiley +1 more source
Hypopituitarism as a result of recurrent craniopharyngioma
The article presents a clinical observation of a patient with a complication of endoscopic endonasal removal of craniopharyngioma in the form of hypopituitarism.
Z. R. Alimetova, A. I. Galieva
doaj +1 more source
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Insights into body composition in pediatric craniopharyngioma patients after surgical treatment
Background: Craniopharyngioma, a benign suprasellar tumor, is typically treated surgically with radiotherapy when indicated. Due to its proximity to the pituitary-hypothalamic region, patients often experience endocrine deficiencies.
Hussein Zaitoon +8 more
doaj +1 more source

